Journals / Solunum / 2015 / Cilt: 17 - Sayı: 3

Does the Finding of Small Airway Obstruction in Pulmonary Function Tests Effect End-Expiratory Carbonmonoxide Level?

Journal
Solunum
Pages
154–158
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presence of SAO does not seem to effect CO levels

📌 3 Key Takeaways

🎯
Objective & Hypothesis:End-expiratory CO level, which is used to test smoking cessation is known to be effected by many factors.
📊
Key Findings & Data:Methods: The study population consisted of cases who applied to smoking cessation clinic between April-December 2014.
💡
Conclusion & Impact:Presence of SAO does not seem to effect CO levels
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

End-expiratory CO level, which is used to test smoking cessation is known to be effected by many factors. We aimed to evaluate effect of small airway obstruction (SAO) on end-expiratory CO levels. Methods: The study population consisted of cases who applied to smoking cessation clinic between April-December 2014. The duration of smoking (pack-years), pulmonary function tests (PFT) and end-expiratory carbonmonoxide (CO) were noted at first visit. The cases were questioned for last time of smoking and amount of cigarettes they smoked within past 12 hours. Pearson correlation test was used to determine factors effecting CO levels. Results: Mean age of 167 cases -112 male (67.1%), 55 female (32.9%) was 38.7±12.7 years. Mean duration of smoking was 23.3±16.4 pack-years, mean CO level was 14.1±6.9 ppm, mean FEF25-75% was 77.2±28.2. Mean period elapsed after last cigarette was 1.5±1.8 hours, mean number of cigarettes smoked within past 12 hours was 7.2±5.0. SAO was found in 50 cases (34.1%). Correlation analyses revealed that CO levels were correlated positively to duration of smoking and amount of cigarettes they smoked within past 12 hours (p=0.03, r=0.228; p=0.000, r=0.511, respectively) and negatively to the last time of smoking (p=0.023, r=0.176). SAO and in PFT was not correlated to CO level (p>0.05). Conclusion: End-expiratory CO level is closely related to duration of smoking, number of cigarettes smoked within past 12 hours and period elapsed after last cigarette. Presence of SAO does not seem to effect CO levels

🔖

Cite This Article

SALEPCİ, B. M., FİDAN, A., PARMAKSIZ, E. T., COŞKUN, E., KIRAL, N., ÇAĞLAYAN, B., CÖMERT, S. Ş., DOĞAN, C. (2015). Does the Finding of Small Airway Obstruction in Pulmonary Function Tests Effect End-Expiratory Carbonmonoxide Level?. Solunum, Cilt: 17 - Sayı: 3, 154–158. https://ajindex.com/articles/314267

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Ryter SW, Choi AM. Carbon monoxide in exhaled breath testing and thera- peutics. J Breath Res 2013; 7: 017111. [CrossRef] Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997; 156: 1140-3. [CrossRef] Yamaya M, Hosoda M, Ishizuka S, Monma M, Matsui T, Suzuki T, et al. Re- lation between exhaled carbon monoxide levels and clinical severity of asthma. Clin Exp Allergy 2001; 31: 417-22. [CrossRef] Zhang J, Yao X, Yu R, Bai J, Sun Y, Huang M, et al. Exhaled carbon monoxide in asthmatics: a meta-analysis. Respir Res 2010; 11: 50. [CrossRef] Jesenak M, Banovcin P, Havlicekova Z, Dobrota D, Babusikova E. Factors influencing the levels of exhaled carbon monoxide in asthmatic children. J Asthma 2014; 51: 900-6. [CrossRef] Zetterquist W, Marteus H, Johannesson M, Nordval SL, Ihre E, Lundberg JO, et al. Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis. Eur Respir J 2002; 20: 92-9. [CrossRef] Beck-Ripp J, Latzin P, Griese M. Exhaled carbon monoxide is not flow de- pendent in children with cystic fibrosis and asthma. Eur J Med Res 2004; 9: 518-22.
  2. Jamrozik K, Vessey M, Fowler G, Wald N, Parker G, Van Vunakis H. Control- led trial of three different anti-smoking interventions in general practice. Br Med J 1984; 288: 1499-502. [CrossRef] Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest 2000; 117: 758-63. [CrossRef] Deveci SE, Deveci F, Acik Y, Ozan AT. The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Respir Med 2004; 98: 551-6. [CrossRef] Hung J, Lin CH, Wang JD, Chan CC. Exhaled carbon monoxide level as an indicator of cigarette consumption in a workplace cessation program in Taiwan. J Formos Med Assoc 2006; 105: 210-3. [CrossRef] Fabricius P, Scharling H, Lokke A, Vestbo J, Lange P. Exhaled CO, a predictor of lung function? Respir Med 2007; 101: 581-6. [CrossRef] Sandberg A, Sköld CM, Grunewald J, Eklund A, Wheelock ÅM. Assessing re- cent smoking status by measuring exhaled carbon monoxide levels. PLoS One 2011; 6: e28864. [CrossRef] Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, et al. Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest 2003; 124: 1749-54. [CrossRef] Crowley TJ, Andrew AE, Cheney J, Zerbe G, Petty TL. Carbon monoxide assessment of smoking in chronic obstructive pulmonary di